BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34831315)

  • 1. Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features.
    Dang LH; Dung NT; Quang LX; Hung LQ; Le NH; Le NTN; Diem NT; Nga NTT; Hung SH; Le NQK
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.
    Cheng F; Zhao Z
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e278-86. PubMed ID: 24644270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An AI-based Prediction Model for Drug-drug Interactions in Osteoporosis and Paget's Diseases from SMILES.
    Hung TNK; Le NQK; Le NH; Van Tuan L; Nguyen TP; Thi C; Kang JH
    Mol Inform; 2022 Jun; 41(6):e2100264. PubMed ID: 34989149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SubGE-DDI: A new prediction model for drug-drug interaction established through biomedical texts and drug-pairs knowledge subgraph enhancement.
    Shi Y; He M; Chen J; Han F; Cai Y
    PLoS Comput Biol; 2024 Apr; 20(4):e1011989. PubMed ID: 38626249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel integrated action crossing method for drug-drug interaction prediction in non-communicable diseases.
    Hunta S; Yooyativong T; Aunsri N
    Comput Methods Programs Biomed; 2018 Sep; 163():183-193. PubMed ID: 30119852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.
    Song D; Chen Y; Min Q; Sun Q; Ye K; Zhou C; Yuan S; Sun Z; Liao J
    J Clin Pharm Ther; 2019 Apr; 44(2):268-275. PubMed ID: 30565313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning.
    Kastrin A; Ferk P; Leskošek B
    PLoS One; 2018; 13(5):e0196865. PubMed ID: 29738537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal CNN-DDI: using multimodal CNN for drug to drug interaction associated events.
    Asfand-E-Yar M; Hashir Q; Shah AA; Malik HAM; Alourani A; Khalil W
    Sci Rep; 2024 Feb; 14(1):4076. PubMed ID: 38374325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2017 Mar; 18(1):140. PubMed ID: 28249566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes.
    Wang NN; Wang XG; Xiong GL; Yang ZY; Lu AP; Chen X; Liu S; Hou TJ; Cao DS
    J Cheminform; 2022 Apr; 14(1):23. PubMed ID: 35428354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal deep learning framework for predicting drug-drug interaction events.
    Deng Y; Xu X; Qiu Y; Xia J; Zhang W; Liu S
    Bioinformatics; 2020 Aug; 36(15):4316-4322. PubMed ID: 32407508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug-drug interactions by graph convolutional network with multi-kernel.
    Wang F; Lei X; Liao B; Wu FX
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
    Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
    J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR Modeling and Prediction of Drug-Drug Interactions.
    Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
    Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection.
    Liu L; Chen L; Zhang YH; Wei L; Cheng S; Kong X; Zheng M; Huang T; Cai YD
    J Biomol Struct Dyn; 2017 Feb; 35(2):312-329. PubMed ID: 26750516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMFUF: a triple matrix factorization-based unified framework for predicting comprehensive drug-drug interactions of new drugs.
    Shi JY; Huang H; Li JX; Lei P; Zhang YN; Dong K; Yiu SM
    BMC Bioinformatics; 2018 Nov; 19(Suppl 14):411. PubMed ID: 30453924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.
    Liu M; Wu Y; Chen Y; Sun J; Zhao Z; Chen XW; Matheny ME; Xu H
    J Am Med Inform Assoc; 2012 Jun; 19(e1):e28-35. PubMed ID: 22718037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging genetic interactions for adverse drug-drug interaction prediction.
    Qian S; Liang S; Yu H
    PLoS Comput Biol; 2019 May; 15(5):e1007068. PubMed ID: 31125330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal health status prediction based on maternal clinical history using machine learning techniques.
    Akbulut A; Ertugrul E; Topcu V
    Comput Methods Programs Biomed; 2018 Sep; 163():87-100. PubMed ID: 30119860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico prediction of chemical-induced hematotoxicity with machine learning and deep learning methods.
    Hua Y; Shi Y; Cui X; Li X
    Mol Divers; 2021 Aug; 25(3):1585-1596. PubMed ID: 34196933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.